CRK and neoplasm: Indeed, EphB4 receptor has been identified as a tumor suppressor in breast cancer, through activation of Abl-Crk antioncogenic pathway [48], while the same receptor presented a tumorigenic potential in mesothelioma, favoring uncontrolled cell growth, migration, and tumor progression [49].